329 related articles for article (PubMed ID: 7989388)
21. [Analysis of the risk factors for local recurrence of giant cell tumor of long bone].
Xu H; Niu X
Zhonghua Zhong Liu Za Zhi; 2014 Jun; 36(6):465-8. PubMed ID: 25241792
[TBL] [Abstract][Full Text] [Related]
22. Segmental excision versus intralesional curettage with adjuvant therapy for giant cell tumour of bone.
Yacob O; Umer M; Gul M; Qadir I
J Orthop Surg (Hong Kong); 2016 Apr; 24(1):88-91. PubMed ID: 27122520
[TBL] [Abstract][Full Text] [Related]
23. [Expanded curettage and bone cement filling combined with internal fixation for the treatment of Campanacci III giant cell tumour of knee joint].
Song Y; Li CF; Shi XT; Cheng YQ; Suo HQ; Liu JG
Zhongguo Gu Shang; 2019 Apr; 32(4):372-376. PubMed ID: 31027417
[TBL] [Abstract][Full Text] [Related]
24. Functional results after giant cell tumor operation near knee joint and the cement radiolucent zone as indicator of recurrence.
Kafchitsas K; Habermann B; Proschek D; Kurth A; Eberhardt C
Anticancer Res; 2010 Sep; 30(9):3795-9. PubMed ID: 20944172
[TBL] [Abstract][Full Text] [Related]
25. Giant cell tumor with pathologic fracture: should we curette or resect?
van der Heijden L; Dijkstra PD; Campanacci DA; Gibbons CL; van de Sande MA
Clin Orthop Relat Res; 2013 Mar; 471(3):820-9. PubMed ID: 22926445
[TBL] [Abstract][Full Text] [Related]
26. The outcomes of treatment of giant cell tumor of bone around the knee.
Asavamongkolkul A; Eamsobhana P; Waikakul S; Phimolsarnti R
J Med Assoc Thai; 2012 Sep; 95 Suppl 9():S122-8. PubMed ID: 23326994
[TBL] [Abstract][Full Text] [Related]
27. Is intralesional treatment of giant cell tumor of the distal radius comparable to resection with respect to local control and functional outcome?
Wysocki RW; Soni E; Virkus WW; Scarborough MT; Leurgans SE; Gitelis S
Clin Orthop Relat Res; 2015 Feb; 473(2):706-15. PubMed ID: 25472928
[TBL] [Abstract][Full Text] [Related]
28. Giant cell tumor of the extremity: retrospective analysis of 621 Chinese patients from one institution.
Niu X; Zhang Q; Hao L; Ding Y; Li Y; Xu H; Liu W
J Bone Joint Surg Am; 2012 Mar; 94(5):461-7. PubMed ID: 22398741
[TBL] [Abstract][Full Text] [Related]
29. [Multicentric giant cell tumor: clinical analysis of 9 cases].
Li X; Guo W; Yang RL; Yang Y
Zhonghua Yi Xue Za Zhi; 2013 Dec; 93(45):3602-5. PubMed ID: 24534311
[TBL] [Abstract][Full Text] [Related]
30. Does pathological fracture affect the rate of local recurrence in patients with a giant cell tumour of bone?: a meta-analysis.
Salunke AA; Chen Y; Chen X; Tan JH; Singh G; Tai BC; Khin LW; Puhaindran ME
Bone Joint J; 2015 Nov; 97-B(11):1566-71. PubMed ID: 26530662
[TBL] [Abstract][Full Text] [Related]
31. Treatment of giant cell tumor of long bone.
Shih HN; Chen YJ; Huang TJ; Ho WP; Hsueh S; Hsu RW
Changgeng Yi Xue Za Zhi; 1996 Mar; 19(1):16-23. PubMed ID: 8935370
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for recurrence of giant cell tumours of bone.
Siddiqui MA; Seng C; Tan MH
J Orthop Surg (Hong Kong); 2014 Apr; 22(1):108-10. PubMed ID: 24781627
[TBL] [Abstract][Full Text] [Related]
33. Re-operation results in osteoarthritic change of knee joints in patients with giant cell tumor of bone.
Suzuki Y; Nishida Y; Yamada Y; Tsukushi S; Sugiura H; Nakashima H; Ishiguro N
Knee; 2007 Oct; 14(5):369-74. PubMed ID: 17601737
[TBL] [Abstract][Full Text] [Related]
34. Does the addition of cement improve the rate of local recurrence after curettage of giant cell tumours in bone?
Gaston CL; Bhumbra R; Watanuki M; Abudu AT; Carter SR; Jeys LM; Tillman RM; Grimer RJ
J Bone Joint Surg Br; 2011 Dec; 93(12):1665-9. PubMed ID: 22161931
[TBL] [Abstract][Full Text] [Related]
35. [Clinical observation of surgical management for recurrent giant cell tumor of bone].
Kong Q; Yang J; Xing R; Tu C; Zhou Y; Zhang H; Duan H
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Jan; 27(1):36-40. PubMed ID: 23427489
[TBL] [Abstract][Full Text] [Related]
36. Similar local recurrence but better function with curettage versus resection for bone giant cell tumor and pathological fracture at presentation.
Tsukamoto S; Mavrogenis AF; Tanzi P; Leone G; Righi A; Akahane M; Kido A; Honoki K; Tanaka Y; Donati DM; Errani C
J Surg Oncol; 2019 Jun; 119(7):864-872. PubMed ID: 30734307
[TBL] [Abstract][Full Text] [Related]
37. Treatment of giant-cell tumor of the pelvis.
Sanjay BK; Frassica FJ; Frassica DA; Unni KK; McLeod RA; Sim FH
J Bone Joint Surg Am; 1993 Oct; 75(10):1466-75. PubMed ID: 8408135
[TBL] [Abstract][Full Text] [Related]
38. Giant cell tumor of bone: oncological and functional results of long-term follow-up.
Oda Y; Miura H; Tsuneyoshi M; Iwamoto Y
Jpn J Clin Oncol; 1998 May; 28(5):323-8. PubMed ID: 9703860
[TBL] [Abstract][Full Text] [Related]
39. Does curettage without adjuvant therapy provide low recurrence rates in giant-cell tumors of bone?
Prosser GH; Baloch KG; Tillman RM; Carter SR; Grimer RJ
Clin Orthop Relat Res; 2005 Jun; (435):211-8. PubMed ID: 15930941
[TBL] [Abstract][Full Text] [Related]
40. Recurrence of curetted and bone-grafted giant-cell tumours with and without adjuvant phenol therapy.
Trieb K; Bitzan P; Lang S; Dominkus M; Kotz R
Eur J Surg Oncol; 2001 Mar; 27(2):200-2. PubMed ID: 11289759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
